Soft tissue sarcoma is rare cancer that can develop in any part of your body, including your feet. It starts in various soft tissues such as muscles, blood vessels, or connective tissue. Most of these ...

Soft tissue sarcoma is metastatic if it has spread to areas in the body away from the location of the original tumor. Soft tissue sarcoma may spread through the bloodstream or lymphatic system to ...

Surgery is the primary treatment for soft tissue sarcoma. It aims to remove cancerous tumors from tissues like muscle and fat. The type of surgery needed depends on the tumor’s characteristics, ...

Soft tissue sarcoma (STS) is a form of cancer that can affect adults and children. However, it is rare, affecting only about 1% of the population. It is possible to cure STS with early detection and ...

Soft tissue sarcomas (STS) are rare and diverse mesenchymal cancers with limited treatment options. Here we undertake comprehensive proteomic profiling of tumour specimens from 321 STS patients ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...

The objective of this study is to develop a multimodal neural network (MMNN) model that analyzes clinical variables and MRI images of a soft tissue sarcoma (STS) patient, to predict overall survival ...

Sarcoma is a rare, complex cancer with over 150 subtypes, each requiring different treatments. Care at specialized centers ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...

Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble studying these cancers because they have lacked good research models. But that ...

Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation ...